U.S. markets closed
  • S&P 500

    3,298.46
    +51.87 (+1.60%)
     
  • Dow 30

    27,173.96
    +358.56 (+1.34%)
     
  • Nasdaq

    10,913.56
    +241.26 (+2.26%)
     
  • Russell 2000

    1,474.91
    +23.09 (+1.59%)
     
  • Crude Oil

    40.04
    -0.27 (-0.67%)
     
  • Gold

    1,864.30
    -12.60 (-0.67%)
     
  • Silver

    22.99
    -0.21 (-0.91%)
     
  • EUR/USD

    1.1639
    -0.0037 (-0.31%)
     
  • 10-Yr Bond

    0.6590
    -0.0070 (-1.05%)
     
  • GBP/USD

    1.2744
    -0.0007 (-0.06%)
     
  • USD/JPY

    105.5590
    +0.1570 (+0.15%)
     
  • BTC-USD

    10,718.59
    +21.60 (+0.20%)
     
  • CMC Crypto 200

    230.19
    +12.36 (+5.67%)
     
  • FTSE 100

    5,842.67
    +19.89 (+0.34%)
     
  • Nikkei 225

    23,204.62
    +116.82 (+0.51%)
     

CLASS ACTION UPDATE for WINS, STAA and VXRT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 30, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

WINS Shareholders Click Here: https://www.zlk.com/pslra-1/wins-finance-holdings-inc-loss-submission-form?prid=8924&wire=1
STAA Shareholders Click Here: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=8924&wire=1
VXRT Shareholders Click Here: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=8924&wire=1

* ADDITIONAL INFORMATION BELOW *

Wins Finance Holdings Inc. (NASDAQ:WINS)

WINS Lawsuit on behalf of: investors who purchased October 31, 2018 - July 6, 2020
Lead Plaintiff Deadline : September 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/wins-finance-holdings-inc-loss-submission-form?prid=8924&wire=1

According to the filed complaint, during the class period, Wins Finance Holdings Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the ultimate repayment of the RMB 580 million Guohong Loan was highly uncertain; (ii) nonpayment of the Guohong Loan would have a significant impact on the Company's financial and operating condition; (iii) weaknesses in Wins's internal control over its financial reporting persisted despite the Company's repeated assurances to investors that it was taking steps to remediate these weaknesses; (iv) the foregoing issues, among others, made the resignation of Wins's independent auditor foreseeably likely; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Staar Surgical Company (NASDAQ:STAA)

STAA Lawsuit on behalf of: investors who purchased February 26, 2020 - August 10, 2020
Lead Plaintiff Deadline : October 19, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=8924&wire=1

According to the filed complaint, during the class period, Staar Surgical Company made materially false and/or misleading statements and/or failed to disclose that: the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) Defendants' public statements were materially false and misleading at all relevant times.

Vaxart, Inc. (NASDAQ:VXRT)

VXRT Lawsuit on behalf of: investors who purchased June 25, 2020 - July 25, 2020
Lead Plaintiff Deadline : October 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=8924&wire=1

According to the filed complaint, during the class period, Vaxart, Inc. made materially false and/or misleading statements and/or failed to disclose that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/603938/CLASS-ACTION-UPDATE-for-WINS-STAA-and-VXRT-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders